⟵ Back to Search Results
BGB-11417-101

Recruiting

Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies

Beigene Study ID info

BGB-11417-101

ClinicalTrials.gov ID info

NCT04277637

China Drug Trials ID info

CTR20231287

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents